Add Formweb to your mobile device
Search results for:
Duovisc
sodium hyaluronate
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| Duovisc | KIT, INTRAOCULAR | - | |
| Healon | LIQUID, INTRAOCULAR | 10 mg/mL | |
| Provisc | LIQUID, INTRAOCULAR | 10 mg/mL | |
| Amvisc Plus | LIQUID, INTRAOCULAR | 16 mg/mL | |
| Hyalgan | SOLUTION, INTRA-ARTICULAR | 10 mg/mL | |
| Supartz | SOLUTION, INTRA-ARTICULAR | 10 mg/mL | |
| Synvisc | SOLUTION, INTRA-ARTICULAR | 16 mg/2 mL | |
| Synvisc One | SOLUTION, INTRA-ARTICULAR | 48 mg/6 mL | |
| Euflexxa | |||
| Hyaluronate derivatives | |||
| HYLAN G F 20 | |||
| SODIUM HYALURONATE OPHTHALMIC |
Last updated: May. 17, 2017
LH current has 7 hyaluronate products available on formulary.
For orthopedic indications: Synvisc and Euflexxa are available as formulary preferred agents.
For ophthalmic indications: Duovisc, Healon, Healon 5, Provisc (0.55mL), and Viscoat (combination product) are available as formulary preferred agents
NON-formulary products include Provisc (0.85mL), Supartz, Hyalgan, Synvisc One, Orthovisc. Requests for a trial to use non-formulary products must be submitted to the P&T committee.